C71T
CANCELLED SECTION 71
23/01/2026
Voltar para busca
Dado oficial do USPTO
NUEVOLUTION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NUEVOLUTION
ST13
US500000079234737Classe
1, 5, 42, 44
Pedido
79234737
Registro
5796494
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
17/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
20/02/2018
Data de registro
09/07/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/01/2026
Última transação
17/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
65
Localização do titular
DK
Examinador
LAM, HAI-LY HUYNH
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Nuevolution A/S
Representantes
Elsa D. Lemoine Amgen Inc.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
DNA preparations for scientific purposes
Classe 5
Pharmaceutical preparations for the treatmentprevention and alleviation of human diseases within oncology and for the treatmentprevention and alleviation of inflammatory diseases; pharmaceutical preparations for the treatmentprevention and alleviation of diseases within oncology and for the treatmentprevention and alleviation of inflammatory diseases; veterinary preparations for the treatment of diseases within oncology and for the treatment of inflammatory diseases; pharmaceutical preparations in the nature of analgesicsantibioticsanti-cancer preparationsanti-infectivesanti-parasiticsantiviralsinsulinhormones and vaccines; biological and non-biological preparations for medical and veterinary purposesfor the treatmentprevention and alleviation of diseases within oncology and for the treatmentprevention and alleviation of inflammatory diseases; enzymes and enzyme preparations for medical and veterinary purposes; DNA preparations for medicalmedical diagnosticveterinary purposes
Classe 42
Scientific research and industrial research in the field of development of drug treatments for diseases within oncology and inflammatory diseases; scientific research in the field of genetics and enzymes; product research and development related to medical and veterinary drugs and preparationsproduct research and development in the biotechnology fieldproduct research and development in the healthcare field; Scientific research and industrial research in the field of developmentprocessing and utilisation of enzymes; molecular research; development for others of scientific research and testing processes and methods for medical and veterinary purposes; development of pharmaceutical preparations for medical and veterinary purposes; scientific research related to identification of drug candidates; scientific research and development in the field of in vitro and in vivo methods for the manufacture of biological and non-biological moleculesof peptides and macrocyclic molecules and derivatives thereof and small molecules and derivatives thereof
Classe 44
Medical screening related to identification of drug candidates
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/07/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/12/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/05/2022
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
09/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/05/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/11/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/10/2019
FIMP
FINAL DISPOSITION PROCESSED
23/10/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
09/07/2019
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/04/2019
PUBO
PUBLISHED FOR OPPOSITION
23/04/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/04/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
25/02/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/02/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
25/02/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/02/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/02/2019
GNFR
FINAL REFUSAL E-MAILED
12/02/2019
CNFR
FINAL REFUSAL WRITTEN
12/02/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2019
ALIE
ASSIGNED TO LIE
16/01/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/01/2019
RFNT
REFUSAL PROCESSED BY IB
27/07/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/07/2018
RFRR
REFUSAL PROCESSED BY MPU
12/07/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/06/2018
CNRT
NON-FINAL ACTION WRITTEN
28/06/2018
MAFR
APPLICATION FILING RECEIPT MAILED
26/06/2018
DOCK
ASSIGNED TO EXAMINER
22/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/06/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/06/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NUEVOLUTION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.